The Gordon Lab will be looking at pre-clinical experiments with MEK inhibitors in cell lines and patient samples with apoptosis by Annexin V or the biologic end point. These experiments will be conducted by Sheila Prachand, Research Lab Manager.
|Effective start/end date||8/1/13 → 8/31/15|
- Tufts Medical Center, Inc. (5010960-SERV//R01CA164311)
- National Cancer Institute (5010960-SERV//R01CA164311)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.